Oliveira, T.
Kendler, D. L.
Schneider, P.
Juby, A. G.
Wani, R. J. http://orcid.org/0000-0002-2422-7758
Packalen, M.
Avcil, S.
Li, S.
Waters-Banker, C.
Graves, E.
McMullen, S.
Brown, J. http://orcid.org/0000-0003-1910-788X
Funding for this research was provided by:
Amgen Canada
Article History
Received: 10 February 2022
Accepted: 25 April 2022
First Online: 3 August 2022
Declarations
:
: Ethics approval was obtained from the Health Research Ethics Board of Alberta – Community Health Committee (HREBA-CHC).
: N/A
: N/A
: SM, CWB, SL, and EG are employed by Medlior, which received funding for the study from Amgen Canada. Amgen Canada was the study sponsor. TO, RW, MP, and SA are employed by Amgen Canada and hold Amgen stock. DLK reports research support from Amgen, Radius Pharma, and Eli Lilly; consulting fees from Amgen, Eli Lilly, and Paladin Pharma and Pfizer; and is on the speakers’ bureau for Amgen and Eli Lilly. JPB reports research support from Mereo BioPharma, Radius Health, and Servier; consulting fees from Amgen, Paladin Labs Inc., Pfizer, and Servier; and is on the speakers’ bureau for Amgen. PS reports research support from Johnson & Johnson, Smith & Nephew, and DePuy Synthes; and has participated in Advisory Boards for Amgen. AGJ has participated in Advisory Boards for Amgen Canada and Paladin Labs Inc; has received no funding for this study.